Entresto Clinical Resource Guide
The 2022 American Heart Association Heart Failure Guidelines advocate for the initiation or transition of all heart failure patients to an ARNI agent, such as Entresto, as a strategy to mitigate morbidity and mortality. Consequently, a growing number of hospice patients are now listed with Entresto on their medication regimen and pose a distinct challenge for hospice healthcare providers in determining coverage of this medication. This guide will serve as a resource to help hospice teams navigate possible therapeutic interchanges to Entresto, based on patient-specific factors.. Download Full PDF
